Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ström Oskar, Fredrik Borgström, Niklas Zethraeus, Olof Johnell, Lars Lidgren, Sari Ponzer, Olle Svensson, Peter Abdon, Ewald Ornstein, Leif Ceder, Karl Göran Thorngren, Ingemar Sernbo & Bengt Jönsson. (2008) Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. Acta Orthopaedica 79:2, pages 269-280.
Read now
Read now
Eva Elinge, Michael Stenvall, Petra Von Heideken Wågert, Britta Löfgren, Yngve Gustafson & Lars Nyberg. (2005) Daily life among the oldest old with and without previous hip fractures. Scandinavian Journal of Occupational Therapy 12:2, pages 51-58.
Read now
Read now
Birgit Hagsten, Olle Svensson & Ann Gardulf. (2004) Early individualized postoperative occupational therapy training in 100 patients improves ADL after hip fractureA randomized trial. Acta Orthopaedica Scandinavica 75:2, pages 177-183.
Read now
Read now
Cecilia Rogmark, Ake Carlsson, Olof Johnell & Ingemar Sernbo. (2003) Costs of internal fixation and arthroplasty for displaced femoral neck fractures. Acta Orthopaedica Scandinavica 74:3, pages 293-298.
Read now
Read now
Martyn J Parker, Glyn A Pryor & John Myles. (2000) 11-year results in 2,846 patients of the Peterborough Hip Fracture Project: Reduced morbidity, mortality and hospital stay. Acta Orthopaedica Scandinavica 71:1, pages 34-38.
Read now
Read now
Articles from other publishers (66)
Johannes Dominik Bastian, Malin Kristin Meier, Raphael Simon Ernst, Jochen Gieger & Andreas Ernst Stuck. (2021) A bibliometric analysis of orthogeriatric care: top 50 articles. European Journal of Trauma and Emergency Surgery 48:3, pages 1673-1682.
Crossref
Crossref
Astrid Coassy, Axel Svedbom, Hervé Locrelle, Roland Chapurlat, Bernard Cortet, Patrice Fardellone, Philippe Orcel, Christian Roux, Fredrik Borgström, John A. Kanis & Thierry Thomas. (2021) Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France—results from the ICUROS study. Osteoporosis International 33:3, pages 625-635.
Crossref
Crossref
Gunhild Hagen, Jon Magnussen, Grethe Tell & Tone Omsland. (2020) Estimating the future burden of hip fractures in Norway. A NOREPOS study. Bone 131, pages 115156.
Crossref
Crossref
A. Bartra, J.-R. Caeiro, M. Mesa-Ramos, I. Etxebarría-Foronda, J. Montejo, P. Carpintero, F. Sorio-Vilela, S. Gatell & L. Canals. (2019) Cost of osteoporotic hip fracture in Spain per Autonomous Region. Revista Española de Cirugía Ortopédica y Traumatología (English Edition) 63:1, pages 56-68.
Crossref
Crossref
A. Bartra, J.-R. Caeiro, M. Mesa-Ramos, I. Etxebarría-Foronda, J. Montejo, P. Carpintero, F. Sorio-Vilela, S. Gatell & L. Canals. (2019) Coste de la fractura de cadera osteoporótica en España por comunidad autónoma. Revista Española de Cirugía Ortopédica y Traumatología 63:1, pages 56-68.
Crossref
Crossref
Jose Ramón Caeiro, Agustí Bartra, Manuel Mesa-Ramos, Íñigo Etxebarría, Jorge Montejo, Pedro Carpintero, Francesc Sorio, Sonia Gatell, Andrea Farré & Laura Canals. (2016) Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study. Calcified Tissue International 100:1, pages 29-39.
Crossref
Crossref
Liv Faksvåg Hektoen, Ingvild Saltvedt, Olav Sletvold, Jorunn L. Helbostad, Hilde Lurås & Vidar Halsteinli. (2016) One-year health and care costs after hip fracture for home-dwelling elderly patients in Norway: Results from the Trondheim Hip Fracture Trial. Scandinavian Journal of Public Health 44:8, pages 791-798.
Crossref
Crossref
Linda Ryen & Mikael Svensson. (2016) Modelling the cost-effectiveness of impact-absorbing flooring in Swedish residential care facilities. The European Journal of Public Health 26:3, pages 407-411.
Crossref
Crossref
C.M. Müller-Mai, U.S. Schulze Raestrup, T. Kostuj, G. Dahlhoff, C. Günster & R. Smektala. (2013) Einjahresverläufe nach proximalen FemurfrakturenOne-year outcomes for proximal femoral fractures. Der Unfallchirurg 118:9, pages 780-794.
Crossref
Crossref
Kristine Thorell, Karin Ranstad, Patrik Midlöv, Lars Borgquist & Anders Halling. (2014) Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatrics 14:1.
Crossref
Crossref
F. Borgström, I. Lekander, M. Ivergård, O. Ström, A. Svedbom, V. Alekna, M. L. Bianchi, P. Clark, M. D. Curiel, H. P. Dimai, M. Jürisson, R. Kallikorm, O. Lesnyak, E. McCloskey, E. Nassonov, K. M. Sanders, S. Silverman, M. Tamulaitiene, T. Thomas, A. N. A. Tosteson, B. Jönsson & J. A. Kanis. (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture. Osteoporosis International 24:3, pages 811-823.
Crossref
Crossref
T. Kostuj, R. Smektala, U. Schulze-Raestrup & C. Müller-Mai. (2011) Pertrochantäre FrakturenPertrochanteric fractures. Der Unfallchirurg 116:1, pages 53-60.
Crossref
Crossref
Kim Brixen, Søren Overgaard, Jeppe Gram, Jesper Ryg, Mette Rothmann, Claire Gudex & Jan Sørensen. 2013. European Instructional Lectures. European Instructional Lectures
3
13
.
Hans Peter Dimai, Kurt Redlich, Monika Peretz, Fredrik Borgström, Uwe Siebert & Jörg Mahlich. (2012) Economic burden of osteoporotic fractures in Austria. Health Economics Review 2:1.
Crossref
Crossref
Rogério Naim Sawaia & William Dias Belangero. (2012) THE MINUS® SYSTEM MINIMALLY INVASIVE TECHNIQUE FOR THE TREATMENT OF TRANTROCHANTERIC FRACTURES. Revista Brasileira de Ortopedia (English Edition) 47:1, pages 113-117.
Crossref
Crossref
Sven Heinrich, Kilian Rapp, Ulrich Rissmann, Clemens Becker & Hans-Helmut König. (2011) Service Use and Costs of Incident Femoral Fractures in Nursing Home Residents in Germany: The Bavarian Fall and Fracture Prevention Project (BF2P2). Journal of the American Medical Directors Association 12:6, pages 459-466.
Crossref
Crossref
A. Duclos, S. Couray-Targe, M. Randrianasolo, S. Hedoux, C. M. Couris, C. Colin & A. M. Schott. (2009) Burden of hip fracture on inpatient care: a before and after population-based study. Osteoporosis International 21:9, pages 1493-1501.
Crossref
Crossref
Brendan J. O'Daly, James C. Walsh, John F. Quinlan, Gavin A. Falk, Robert Stapleton, William R. Quinlan & S. Kieran O'Rourke. (2010) Serum albumin and total lymphocyte count as predictors of outcome in hip fractures. Clinical Nutrition 29:1, pages 89-93.
Crossref
Crossref
Terence W. O’Neill. 2010. Osteoporosis in Men. Osteoporosis in Men
385
393
.
Jari ParkkariPekka Kannus. (2009) Hip protectors for preventing hip fractures among elderly adults. Aging Health 5:4, pages 509-517.
Crossref
Crossref
O. Ström, F. Borgström, J. A. Kanis & B. Jönsson. (2008) Incorporating adherence into health economic modelling of osteoporosis. Osteoporosis International 20:1, pages 23-34.
Crossref
Crossref
Fredrik Borgström & John A. Kanis. (2008) Health economics of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 22:5, pages 885-900.
Crossref
Crossref
Ingrid Lekander, Fredrik Borgström, Oskar Ström, Niklas Zethraeus & John A. Kanis. (2008) Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK—Results based on the Women's Health Initiative randomised controlled trial. Bone 42:2, pages 294-306.
Crossref
Crossref
Lukas A. Holzer & Gerold Holzer. (2007) Die Bedeutung von Hüftprotektoren zur Prävention von hüftnahen Frakturen bei älteren MenschenThe role of hip protectors in the prevention of hip fractures in older people. Wiener Medizinische Wochenschrift 157:15-16, pages 381-387.
Crossref
Crossref
L.S. Costa, R.M.V.R. Almeida & R.S. Pinheiro. (2007) Access by elderly patients with hip fractures to public hospitals in the city of Rio de Janeiro, Brazil. Public Health 121:7, pages 525-528.
Crossref
Crossref
O. Ström, F. Borgström, S. S. Sen, S. Boonen, P. Haentjens, O. Johnell & J. A. Kanis. (2007) Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial. Osteoporosis International 18:8, pages 1047-1061.
Crossref
Crossref
Fredrik Borgström, Patrik Sobocki, Oskar Ström & Bengt Jönsson. (2007) The societal burden of osteoporosis in Sweden. Bone 40:6, pages 1602-1609.
Crossref
Crossref
I. M. Giversen. (2007) Time trends of mortality after first hip fractures. Osteoporosis International 18:6, pages 721-732.
Crossref
Crossref
E. Seeman, J. Compston, J. Adachi, M. L. Brandi, C. Cooper, B. Dawson-Hughes, B. Jönsson, H. Pols & J. A. Cramer. (2007) Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporosis International 18:6, pages 711-719.
Crossref
Crossref
Jonas Lundkvist, Nils Wilking, Stig Holmberg & Linus Jönsson. (2006) Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden. Breast Cancer Research and Treatment 102:3, pages 289-299.
Crossref
Crossref
N. Zethraeus, F. Borgström, O. Ström, J. A. Kanis & B. Jönsson. (2006) Cost-effectiveness of the treatment and prevention of osteoporosis—a review of the literature and a reference model. Osteoporosis International 18:1, pages 9-23.
Crossref
Crossref
A. Esquenazi. (2006) Improvements in healthcare and cost benefits associated with botulinum toxin treatment of spasticity and muscle overactivity. European Journal of Neurology 13:s4, pages 27-34.
Crossref
Crossref
F. Borgström, B. Jönsson, O. Ström & J. A. Kanis. (2006) An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting. Osteoporosis International 17:12, pages 1781-1793.
Crossref
Crossref
E. I. O. Vidal, C. M. Coeli, R. S. Pinheiro & K. R. CamargoJrJr. (2006) Mortality within 1 year after hip fracture surgical repair in the elderly according to postoperative period: a probabilistic record linkage study in Brazil. Osteoporosis International 17:10, pages 1569-1576.
Crossref
Crossref
F. Borgström, O. Johnell, J. A. Kanis, B. Jönsson & C. Rehnberg. (2006) At what hip fracture risk is it cost-effective to treat?. Osteoporosis International 17:10, pages 1459-1471.
Crossref
Crossref
F. Borgström, Å. Carlsson, H. Sintonen, S. Boonen, P. Haentjens, R. Burge, O. Johnell, B. Jönsson & J. A. Kanis. (2006) The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporosis International 17:7, pages 996-1007.
Crossref
Crossref
Fredrik Borgström, Niklas Zethraeus, Olof Johnell, Lars Lidgren, Sari Ponzer, Olle Svensson, Peter Abdon, Ewald Ornstein, Karl Lunsjö, Karl Göran Thorngren, Ingemar Sernbo, Clas Rehnberg & Bengt Jönsson. (2005) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporosis International 17:5, pages 637-650.
Crossref
Crossref
Torsten Johansson, Margareta Bachrach-Lindström, Per Aspenberg, Dick Jonsson & Ola Wahlström. (2005) The total costs of a displaced femoral neck fracture: comparison of internal fixation and total hip replacement. International Orthopaedics 30:1, pages 1-6.
Crossref
Crossref
J. Lundkvist, O. Johnell, C. Cooper & D. Sykes. (2005) Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women. Osteoporosis International 17:2, pages 201-211.
Crossref
Crossref
Niklas Zethraeus, Fredrik Borgström, Bengt Jönsson & John Kanis. (2005) Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: Results based on the Women's Health Initiative randomized controlled trial. International Journal of Technology Assessment in Health Care 21:4, pages 433-441.
Crossref
Crossref
Virgínia Angélica Lopes Silveira, Marta Maria das Chagas Medeiros, João Macedo Coelho-Filho, Rosa Salani Mota, Jamile Coelho Soares Noleto, Felipe Silveira da Costa, Francisco José Oliveira de Pontes, Juliana Barbosa Sobral, Raimundo Felipe Aguiar, Ângela Cristina Leal & Cristiano Magalhães Clemente. (2005) Incidência de fratura do quadril em área urbana do Nordeste brasileiro. Cadernos de Saúde Pública 21:3, pages 907-912.
Crossref
Crossref
Birgitta Olofsson, Maria Lundstrom, Bengt Borssen, Lars Nyberg & Yngve Gustafson. (2005) Delirium is associated with poor rehabilitation outcome in elderly patients treated for femoral neck fractures. Scandinavian Journal of Caring Sciences 19:2, pages 119-127.
Crossref
Crossref
Palle Mark Christensen, Kim Brixen, Dorte Gyrd-Hansen & Ivar Sonbo Kristiansen. (2005) Cost-Effectiveness of Alendronate in the Prevention of Osteoporotic Fractures in Danish Women. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 96:5, pages 387-396.
Crossref
Crossref
Lars Nyberg, Lillemor Lundin-Olsson, Björn Sondell, Anders Backman, Kenneth Holmlund, Staffan Eriksson, Michael Stenvall, Erik Rosendahl, Marcus Maxhall & Gustaf Bucht. (2005) The development of a virtual reality system to study tendency of falling among older people. International Journal on Disability and Human Development 4:3.
Crossref
Crossref
R. Lindsay, R. T. Burge & D. M. Strauss. (2004) One year outcomes and costs following a vertebral fracture. Osteoporosis International 16:1, pages 78-85.
Crossref
Crossref
John A. Kanis, Olof Johnell, Anders Oden, Frederik Borgstrom, Helena Johansson, Chris De Laet & Bengt Jönsson. (2004) Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporosis International 16:1, pages 6-14.
Crossref
Crossref
Tatsuro Ishizaki, Yuichi Imanaka, Eunhwan Oh, Kazuaki Kuwabara, Masahiro Hirose, Kenshi Hayashida & Yoshiaki Harada. (2004) Association of hospital resource use with comorbidity status and patient age among hip fracture patients in Japan. Health Policy 69:2, pages 179-187.
Crossref
Crossref
Fredrik Borgström, Olof Johnell, Bengt Jönsson, Niklas Zethraeus & Shuvayu S Sen. (2004) Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden. Bone 34:6, pages 1064-1071.
Crossref
Crossref
Shay Shabat, Eyal Heller, Gideon Mann, Reuben Gepstein, Brian Fredman & Meir Nyska. (2003) Economic Consequences of Operative Delay for Hip Fractures in a Non-Profit Institution. Orthopedics 26:12, pages 1197-1199.
Crossref
Crossref
Isao Ohnishi, Katsuhiko Oikawa, Koichiro Tsuji, Tadashi Ichikawa & Takahide Kurokawa. (2003) A femoral neck fracture model in rabbits. Journal of Biomechanics 36:3, pages 431-442.
Crossref
Crossref
Johan J. Polder, Romke van Balen, Ewout W. Steyerberg, Herman J.M. Cools & J. Dik F. Habbema. (2002) A cost‐minimisation study of alternative discharge policies after hip fracture repair. Health Economics 12:2, pages 87-100.
Crossref
Crossref
Olof Johnell, Bengt J??nsson, Linus J??nsson & Dennis Black. (2003) Cost Effectiveness of Alendronate (Fosamax??) for the Treatment of Osteoporosis and Prevention of Fractures. PharmacoEconomics 21:5, pages 305-314.
Crossref
Crossref
Cynthia L. Leibson, Anna N. A. Tosteson, Sherine E. Gabriel, Jeanine E. Ransom & L. Joseph MeltonIIIIII. (2002) Mortality, Disability, and Nursing Home Use for Persons with and without Hip Fracture: A Population-Based Study. Journal of the American Geriatrics Society 50:10, pages 1644-1650.
Crossref
Crossref
J.A Kanis, O Johnell, A Oden, C De Laet, A Oglesby & B Jönsson. (2002) Intervention thresholds for osteoporosis. Bone 31:1, pages 26-31.
Crossref
Crossref
E Puntila, H Kröger, T Lakka, M Tuppurainen, J Jurvelin & R Honkanen. (2001) Leisure-time physical activity and rate of bone loss among peri- and postmenopausal women: a longitudinal study. Bone 29:5, pages 442-446.
Crossref
Crossref
Patrick Haentjens, Philippe Autier, Martine Barette & Steven Boonen. (2001) The Economic Cost of Hip Fractures Among Elderly Women. The Journal of Bone and Joint Surgery-American Volume 83:4, pages 493-500.
Crossref
Crossref
Peter Vestergaard, Lars Rejnmark & Leif Mosekilde. (2001) Hip Fracture Prevention. PharmacoEconomics 19:Parts 1 and 2, pages 449-468.
Crossref
Crossref
C.F. Roques, E. Maupas, P. Marque & M. Chatain. (2000) Fractures de l'extrémité supérieure du fémur Les enjeux économiques. Annales de Réadaptation et de Médecine Physique 43:5, pages 215-218.
Crossref
Crossref
T.K. Kakarlapudi, A. Santini, S.A. Shahane & David Douglas. (2000) The cost of treatment of distal radial fractures. Injury 31:4, pages 229-232.
Crossref
Crossref
Kenneth J. Koval & Joseph D. ZuckermanKenneth J. Koval & Joseph D. Zuckerman. 2000. Hip Fractures. Hip Fractures
303
312
.
T.M Huusko, P Karppi, V Avikainen, H Kautiainen & R Sulkava. (1999) The changing picture of hip fractures: dramatic change in age distribution and no change in age-adjusted incidence within 10 years in central Finland. Bone 24:3, pages 257-259.
Crossref
Crossref
W. Dere, B. Avouac, M. Boers, M. Buxton, C. Christiansen, A. Dawson, C. Gennari, F. Guillemin, H. Lawetz, F. Ornskov, I. Roumagnac & J. Y. Reginster. (2013) Recommendations for the Health Economics Analysis to be Performed with a Drug to be Registered in Prevention or Treatment of Osteoporosis. Calcified Tissue International 63:2, pages 93-97.
Crossref
Crossref
L. Elffors. (2013) Are osteoporotic fractures due to osteoporosis?. Aging Clinical and Experimental Research 10:3, pages 191-204.
Crossref
Crossref
L. Ceder. (2018) Hip Fracture Treatment: From Local to Multinational Assessment. HIP International 8:2, pages 99-101.
Crossref
Crossref
Niklas Zethraeus & Ulf-G Gerdtham. (2009) Estimating the Costs of Hip Fracture and Potential Savings. International Journal of Technology Assessment in Health Care 14:2, pages 255-267.
Crossref
Crossref
Olof Johnell. (1997) The socioeconomic burden of fractures: Today and in the 21st century. The American Journal of Medicine 103:2, pages S20-S26.
Crossref
Crossref